Fecal Spillage at Colectomy: Prophylaxis Window or Treatment Course?
A single patient, forty-eight hours past a sigmoid colectomy that spilled stool before the field could be controlled. The disagreement is over whether the antibiotics he's already receiving are still prophylaxis, four days of treatment for a source-controlled infection, or something the surgeon wants to extend further on comorbidity grounds alone.
R.D., a 58-year-old man, has managed the same hardware store for twenty-two years and was three days from a fishing trip with his two grandsons when a dull ache in his lower abdomen turned, over about thirty-six hours, into fever and pain sharp enough that his wife drove him to the emergency department rather than waiting for a Monday appointment. CT showed sigmoid diverticulitis with a 4cm pericolonic abscess, and when overnight drainage failed to control his fever, he went to the operating room for a sigmoid colectomy. His history includes type 2 diabetes, poorly controlled (A1c 8.1% on metformin alone), and obesity (BMI 34) — both real, independently established surgical-site-infection risk factors that slow tissue healing on their own, which is why his case was already flagged for closer wound monitoring before anyone knew the operation itself would go sideways.
What actually happened in the OR is the reason his case is still open two days later: dissecting the inflamed segment free opened the abscess cavity, and stool spilled into the pelvis before the field could be controlled — gross contamination, not the clean-contaminated field a routine sigmoid resection is supposed to produce. The surgeon irrigated with several liters of saline, achieved what he is calling adequate source control, and closed with a primary anastomosis. The question dividing the team isn't whether R.D. needs antibiotics — everyone agrees he does — it's whether what he's receiving is still the 24-hour surgical prophylaxis his diabetes and obesity already qualified him for, or whether the spillage converted this into a complicated intra-abdominal infection requiring a defined treatment course. STOP-IT, the largest randomized trial to actually test this question, enrolled patients with exactly this profile — source-controlled intra-abdominal infection — and found a fixed four-day course performed identically to a longer, symptom-guided one; the trial's own entry criteria required documented source control, which is precisely the fact this case's outcome turns on. The distinction the team keeps circling is whether "contaminated" on the operative wound classification actually means "infected" under the treatment framework STOP-IT was built to answer, or whether it's simply a more heavily loaded version of the same prophylaxis question everyone already agreed 24 hours would settle.
On rounds, postoperative day two
By the letter of the ASHP/IDSA/SHEA/SIS surgical antimicrobial prophylaxis guideline, R.D. never had a positive culture and was never formally diagnosed with an infection — what he received was prophylaxis, and prophylaxis stops within twenty-four hours of incision closure. He's now at hour forty-eight. Extending it hasn't been shown to reduce surgical-site infection in any of the trials the guideline is built on, and every extra day is measurable C. difficile and resistance risk he's carrying for no proven benefit.
You're right that nothing in his chart says "infection" in so many words — no positive culture, no formal diagnosis note. But gross fecal spillage into the pelvis, controlled only by irrigation, is functionally identical to what STOP-IT actually enrolled: complicated intra-abdominal infection with source control achieved intraoperatively. That trial randomized 518 patients — half to a fixed four-day course, half to a longer course continued until two days after fever, leukocytosis, and ileus had resolved, capped at ten days — and found no difference between the groups in its composite of surgical-site infection, recurrent intra-abdominal infection, or death at thirty days. There's no arm in that trial that stopped at twenty-four hours, because nobody who designed it thought contaminated-and-source-controlled was the same category as clean prophylaxis.
The stewardship framework you're citing was built for uncomplicated clean and clean-contaminated cases — it was never validated against a field that was actively spilling stool an hour before close.
I'll take the four days SIS and STOP-IT actually support over either twenty-four hours or an open-ended week — I don't have evidence for going longer than that, I have a feeling about his diabetes and his BMI, and I know the difference.
You're both closer to right than I am on the data. I don't have a trial behind extending past what STOP-IT tested, just years of watching diabetic, obese patients with real contamination fail on paper-correct courses. That's not evidence, it's risk tolerance, and I recognize the difference — which is why I'm not asking to go past day four here, just naming why I'd still watch him more closely than the trial average would suggest.
Agreed: a fixed four-day total antibiotic course from the time of intraoperative source control, not the 24-hour prophylaxis window and not an open-ended extension, with reassessment at day 4 based on his fever curve and white count rather than a preset finish date.
Not agreed: whether his diabetes and obesity should generically push future similarly contaminated, source-controlled cases toward the higher end of guideline-supported ranges. The surgeon wants comorbidity-driven defaults for patients built like him; the infectious disease physician wants each case individually matched against STOP-IT's actual population rather than extended by comorbidity instinct. Neither position was resolved tonight — both agreed R.D.'s own plan doesn't depend on settling it.